{"version":"1.0","type":"link","title":"Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.","author_name":"Jameson GS 외","author_url":"https://prs-insight.online/author/Jameson%20GS","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/150612","thumbnail_width":1200,"thumbnail_height":630}